image
Healthcare - Medical - Care Facilities - NASDAQ - US
$ 10.48
-2.06 %
$ 157 M
Market Cap
-104.8
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one JYNT stock under the worst case scenario is HIDDEN Compared to the current market price of 10.5 USD, The Joint Corp. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one JYNT stock under the base case scenario is HIDDEN Compared to the current market price of 10.5 USD, The Joint Corp. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one JYNT stock under the best case scenario is HIDDEN Compared to the current market price of 10.5 USD, The Joint Corp. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart JYNT

image
$13.0$13.0$12.5$12.5$12.0$12.0$11.5$11.5$11.0$11.0$10.5$10.5$10.0$10.0$9.5$9.515 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
51.9 M REVENUE
-55.91%
-1.76 M OPERATING INCOME
15.34%
-8.53 M NET INCOME
12.53%
9.42 M OPERATING CASH FLOW
-35.85%
-632 K INVESTING CASH FLOW
89.79%
-2 M FINANCING CASH FLOW
-1149.41%
14.4 REVENUE
47841553.67%
944 B OPERATING INCOME
29620861.82%
-2.72 M NET INCOME
14.21%
4.13 M OPERATING CASH FLOW
19.78%
-104 K INVESTING CASH FLOW
-10.97%
-24.9 K FINANCING CASH FLOW
-288.27%
Balance Sheet The Joint Corp.
image
Current Assets 72.2 M
Cash & Short-Term Investments 25.1 M
Receivables 2.59 M
Other Current Assets 44.6 M
Non-Current Assets 8.23 M
Long-Term Investments 0
PP&E 3.41 M
Other Non-Current Assets 4.81 M
31.15 %3.22 %55.40 %4.24 %5.99 %Total Assets$80.4m
Current Liabilities 49.4 M
Accounts Payable 1.75 M
Short-Term Debt 448 K
Other Current Liabilities 47.2 M
Non-Current Liabilities 13.1 M
Long-Term Debt 0
Other Non-Current Liabilities 13.1 M
2.80 %75.48 %21.00 %Total Liabilities$62.5m
EFFICIENCY
Earnings Waterfall The Joint Corp.
image
Revenue 51.9 M
Cost Of Revenue 11.5 M
Gross Profit 40.4 M
Operating Expenses 42.1 M
Operating Income -1.76 M
Other Expenses 6.77 M
Net Income -8.53 M
60m60m50m50m40m40m30m30m20m20m10m10m00(10m)(10m)52m(12m)40m(42m)(2m)(7m)(9m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
77.81% GROSS MARGIN
77.81%
-3.38% OPERATING MARGIN
-3.38%
-16.44% NET MARGIN
-16.44%
-47.60% ROE
-47.60%
-10.61% ROA
-10.61%
-5.80% ROIC
-5.80%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis The Joint Corp.
image
10m10m5m5m00(5m)(5m)(10m)(10m)(15m)(15m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -8.53 M
Depreciation & Amortization 4.72 M
Capital Expenditures -1.19 M
Stock-Based Compensation 1.68 M
Change in Working Capital 1.16 M
Others 1.58
Free Cash Flow 8.23 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets The Joint Corp.
image
Wall Street analysts predict an average 1-year price target for JYNT of $20 , with forecasts ranging from a low of $20 to a high of $20 .
JYNT Lowest Price Target Wall Street Target
20 USD 90.84%
JYNT Average Price Target Wall Street Target
20 USD 90.84%
JYNT Highest Price Target Wall Street Target
20 USD 90.84%
Price
Max Price Target
Min Price Target
Average Price Target
20201818161614141212101088May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 8
6. Ownership
Insider Ownership The Joint Corp.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Alumis and ACELYRIN File Joint Definitive Proxy Statement for Proposed Merger Stockholders to benefit from differentiated late-stage portfolio of therapies and strong balance sheet Boards unanimously recommend stockholders vote “FOR” the merger Transaction expected to be completed in second quarter of 2025 SOUTH SAN FRANCISCO, Calif. and LOS ANGELES, April 04, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients with immune-mediated diseases, and ACELYRIN, INC. globenewswire.com - 1 week ago
NUBURU Advances Joint Development Agreement to Innovate Laser Applications in Defense Sector CENTENNIAL, Colo.--(BUSINESS WIRE)--NUBURU, Inc. (NYSE American: BURU), a leader in high-power and high-brightness industrial blue laser technology, is excited to announce the signing of a Joint-Pursuit Agreement (JPA) with a defense-tech company, marking a significant milestone in its strategic expansion into the defense sector. This agreement follows the successful completion of an initial 20% acquisition interest in a defense and security hub, announced on March 12, 2025. This endeavor is ex. businesswire.com - 1 week ago
Oasis Venture Holdings, a Joint Venture between Ball Corporation and Ayna.AI, announces the appointment of David Cuthbert as its new Chief Executive Officer ROME, Ga., March 31, 2025 (GLOBE NEWSWIRE) -- Oasis Venture Holdings, a recently announced Joint Venture between Ball Corporation and Ayna.AI, is proud to announce the appointment of David Cuthbert as its new Chief Executive Officer. Cuthbert, a distinguished veteran and proven business leader, brings a wealth of experience in driving growth and sustainability-focused initiatives across multiple industries. globenewswire.com - 1 week ago
Sandstorm Gold Royalties: Hod Maden Joint Venture to Invest Up to $100M to Advance Critical Path; Underpins Long-term Outlook VANCOUVER, BC , March 31, 2025 /PRNewswire/ - Sandstorm Gold Ltd. ("Sandstorm Gold Royalties", "Sandstorm" or the "Company") (NYSE: SAND) (TSX: SSL) is pleased to report that SSR Mining Inc. ("SSR Mining") has released its 2025 guidance, including anticipated capital expenditure for the Hod Maden gold-copper project in Türkiye. prnewswire.com - 1 week ago
The Joint Chiropractic Establishes Major Scholarship at Northwestern Health Sciences University BLOOMINGTON, Minn. , March 31, 2025 /PRNewswire/ -- Northwestern Health Sciences University (NWHSU), a leading health sciences university, announced the creation of a major endowed scholarship by The Joint Corp., the nation's largest franchisor of chiropractic care through The Joint Chiropractic ® network. prnewswire.com - 1 week ago
Azure Holding Group Corp ($AZRH) Forms Joint Venture with Mountain V, Begins First Phase of Natural Gas and Oil Drilling Program Appalachian Mountain Energy, the joint venture, will drill new wells and rework existing wells currently owned and operated by Mountain V Oil & Gas across all 300,000 surface and mineral acres across the Appalachian Basin and Permian Basin that are currently held by production by Mountain V Oil & Gas. NEW YORK CITY, NY / ACCESS Newswire / March 31, 2025 / Azure Holding Group Corp. (OTC PINK:$AZRH, being renamed American Industries) and Mountain V Oil & Gas have officially formed a joint venture. accessnewswire.com - 1 week ago
Cornish Metals Announces Joint Broker Update VANCOUVER, British Columbia, March 31, 2025 (GLOBE NEWSWIRE) -- Cornish Metals Inc. (AIM/TSX-V: CUSN) (“Cornish Metals” or the “Company”), a mineral exploration and development company focused on advancing its 100% owned and permitted South Crofty tin project in Cornwall, United Kingdom, announces that with effect from today's date SP Angel Corporate Finance LLP and H&P Advisory Limited will act as joint brokers to the Company. globenewswire.com - 1 week ago
IFF and Kemira Form Joint Venture To Produce Sustainable Biobased Materials at Scale NEW YORK--(BUSINESS WIRE)--IFF (NYSE:IFF) and Kemira announced the formation of Alpha Bio, a joint venture aimed at commercial-scale production of renewable biobased materials. With an investment of approximately €130 million, the Alpha Bio facility will start production in late 2027, converting up to 44,000 MT of plant sugars to bioproducts, including high-performance biopolymers for use in various applications, such as home and personal care and industrial solutions. Alpha Bio's production wi. businesswire.com - 2 weeks ago
Bridger Aerospace and Positive Aviation Announce Joint Partnership for the Development of Water Scooping Aircraft BELGRADE, Mont. and BLAGNAC, France, March 25, 2025 (GLOBE NEWSWIRE) -- Bridger Aerospace Group Holdings, Inc. (“Bridger” or “Bridger Aerospace”) (NASDAQ: BAER, BAERW), one of the nation's largest aerial firefighting companies, and Positive Aviation, Inc. (“PA”), a Blagnac, France-based engineering company, announced today that they have entered into a Memorandum of Understanding (“MOU”) designating Bridger as the exclusive North American launch customer for PA's FF72 aircraft, a state-of-the-art, reliable, and efficient amphibious water-scooping firefighting aircraft derived from an ATR 72-600. The partnership was officially unveiled today at the Aerial Fire Fighting Series: Europe Conference and Exhibition (“AFFE25”) held at the Centre de Congrès Cité Mondiale in Bordeaux, France, and remains subject to negotiation of a definitive collaboration agreement between the parties on terms consistent with the MOU. globenewswire.com - 2 weeks ago
180 Degree Capital Corp. Notes Filing of Preliminary Joint Proxy Statement/Prospectus for Proposed Business Combination With Mount Logan Capital Inc. and Provides Interim Update on Developments in Q1 2025 MONTCLAIR, N.J., March 24, 2025 (GLOBE NEWSWIRE) -- 180 Degree Capital Corp. (NASDAQ:TURN) (“180 Degree Capital”) today noted that it had filed a preliminary joint proxy statement/prospectus on Schedule 14A with the Securities and Exchange Commission (“SEC”) regarding its proposed merger with Mount Logan Capital Inc. (“Mount Logan”) in an all-stock transaction (the “Business Combination”). As noted in its original press release issued on January 17, 2025, the surviving entity is expected to be a Delaware corporation operating as Mount Logan Capital Inc. (“New Mount Logan”) listed on Nasdaq under the symbol “MLCI”. In connection with the Business Combination, 180 Degree Capital shareholders will receive proportionate ownership of New Mount Logan determined by reference to 180 Degree Capital's NAV at closing relative to a valuation of Mount Logan of approximately $67.4 million at signing, subject to certain pre-closing adjustments. globenewswire.com - 2 weeks ago
Joint Stock Company Kaspi.kz issues USD denominated Eurobond NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. THIS IS AN ANNOUNCEMENT AND NOT AN OFFER TO SELL OR AN INVITATION TO PURCHASE OR SUBSCRIBE FOR ANY SECURITIES NOR A CIRCULAR OR PROSPECTUS OR EQUIVALENT DOCUMENT AND INVESTORS OR PROSPECTIVE INVESTORS SHOULD NOT MAKE INVESTMENT DECISIONS ON THE BASIS OF ITS CONTENTS. globenewswire.com - 3 weeks ago
FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting HOUSTON, March 21, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Hamid Khoja, Ph.D., Chief Scientific Officer of FibroBiologics, will present on FibroBiologics' unique fibroblast cell-based approach for the potential treatment of chronic diseases at The German-Nordic Joint Extracellular Matrix Meeting in Freiburg, Germany, from March 26-28, 2025. The joint meeting is an annual opportunity to showcase advances in extracellular matrix biology. globenewswire.com - 3 weeks ago
8. Profile Summary

The Joint Corp. JYNT

image
COUNTRY US
INDUSTRY Medical - Care Facilities
MARKET CAP $ 157 M
Dividend Yield 0.00%
Description The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Contact 16767 North Perimeter Drive, Scottsdale, AZ, 85260 https://www.thejoint.com
IPO Date Nov. 11, 2014
Employees 443
Officers Ms. Beth Gross Senior Vice President of Human Resources Mr. Jake Singleton CPA Chief Financial Officer Ms. Lori I. Abou Habib Chief Marketing Officer Dr. Steven Knauf Vice President of Chiropractic & Compliance Mr. Craig P. Colmar J.D. Secretary Mr. Craig M. Sherwood Senior Vice President of Development Mr. Charles Nelles Chief Technology Officer Mr. Sanjiv Razdan Chief Executive Officer, President & Director